Why the study?
Italian law mandates annual preparticipation evaluation to detect cardiovascular diseases risking sudden death, but its diagnostic yield, disqualification rate, and costs warranted investigation.
What is the diagnostic yield, rate of disqualification, and cost of the Italian preparticipation evaluation programme in apparently healthy athletes?
What is the diagnostic yield, rate of disqualification, and cost of the Italian preparticipation evaluation programme in apparently healthy athletes?
The Italian preparticipation evaluation model is a low-cost strategy (€79 per athlete) that identifies cardiovascular disease in 1.5% of apparently healthy athletes.
PPE data support feasibility in mandated settings; leaves open net benefit and generalizability to other populations.
INTRODUCTION: Italian law mandates that every competitive athlete must undergo annual preparticipation evaluation (PPE) to identify cardiovascular (CV) diseases that pose a risk of sudden death (SD) during sport and other conditions that may threaten the athlete's health. We investigated the diagnostic yield, rate of disqualification and costs of our PPE. METHODS: We included 5910 consecutive apparently healthy athletes (61% males, mean age 15±4 years) who underwent annual PPE performed by a sports medicine specialist. The PPE included history, physical examination, weight, height and blood pressure measurement, test of visual acuity, spirometry, urine chemistry, resting 12-lead ECG and exercise testing with ECG monitoring. In cases of abnormal findings, we carried out second-line investigations. RESULTS: During a 12-month study period, 5.326 (90.2%) athletes were cleared for competition after a normal first-line evaluation and 584 (9.8%) underwent one or more further examinations. Of those, 88 (1.5%) were diagnosed to have a CV disease (including 18 (0.3%) at-risk of SD) and 31 (0.5%) had a non-CV diagnosis. A total of 32 (0.5%) athletes were temporarily (n=15) or permanently (n=17) disqualified from competitive sports. The average cost per athlete was €79, which consisted of €64 (80%) for first-line evaluations and €15 (20%) for additional investigations. CONCLUSION: PPE according to the Italian model identified a range of diseases in 2.0% of apparently healthy athletes at an average cost of €79.
No takes yet. Share an insight, caveat, or question.
Vessella et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: